Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Faster and sustained improvement in health-related quality of life (HRQoL) for newly diagnosed multiple myeloma (NDMM) patients ineligible for transplant treated with daratumumab, lenalidomide, and dexamethasone (D-Rd) versus Rd alone: MAIA.
PaperCitations, authors & open-access status
Faster and sustained improvement in health-related quality of life (HRQoL) for newly diagnosed multiple myeloma (NDMM) patients ineligible for transplant treated with daratumumab, lenalidomide, and dexamethasone (D-Rd) versus Rd alone: MAIA. is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 14 citations, 2019 year and closed oa status.
14
Citations
2019
Year
closed
OA Status